{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:40:38Z","timestamp":1790732438535,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"am","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.purol.2020.09.004","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T20:27:09Z","timestamp":1605731229000},"page":"920-930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Traitement du syndrome clinique d\u2019hyperactivit\u00e9 v\u00e9sicale non neurologique r\u00e9fractaire"],"prefix":"10.1016","volume":"30","author":[{"given":"X.","family":"Gam\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ph\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2020.09.004_bib0365","doi-asserted-by":"crossref","first-page":"E142","DOI":"10.5489\/cuaj.4586","article-title":"CUA guideline on adult overactive bladder","volume":"11","author":"Corcos","year":"2017","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.purol.2020.09.004_bib0370","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1185\/03007995.2013.860021","article-title":"Defining response and non-response to treatment in patients with overactive bladder: a systematic review","volume":"30","author":"Goldman","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.purol.2020.09.004_bib0375","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.purol.2014.01.004","article-title":"Quelle d\u00e9finition pour l\u2019hyperactivit\u00e9 v\u00e9sicale r\u00e9fractaire\u00a0?","volume":"24","author":"Amarenco","year":"2014","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0380","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/nau.22512","article-title":"How to define a refractory idiopathic overactive bladder?","volume":"34","author":"Ph\u00e9","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2020.09.004_bib0385","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/JU.0000000000000309","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU Guideline Amendment 2019","volume":"202","author":"Lightner","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0390","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/luts.12304","article-title":"Current management of refractory overactive bladder","volume":"12","author":"Chen","year":"2020","journal-title":"Low Urin Tract Symptoms"},{"key":"10.1016\/j.purol.2020.09.004_bib0395","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ucl.2004.09.007","article-title":"Percutaneous neuromodulation","volume":"32","author":"Cooperberg","year":"2005","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.purol.2020.09.004_bib0400","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s41999-017-0013-3","article-title":"Efficacy of posterior tibial nerve stimulation (PTNS) on overactive bladder in older adults","volume":"9","author":"Hentzen","year":"2018","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.purol.2020.09.004_bib0405","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.medengphy.2018.01.004","article-title":"A finite element modeling study of peripheral nerve recruitment by percutaneous tibial nerve stimulation in the human lower leg","volume":"53","author":"Elder","year":"2018","journal-title":"Med Eng Phys"},{"key":"10.1016\/j.purol.2020.09.004_bib0410","first-page":"3129","article-title":"Co-activation of saphenous nerve fibers: a potential therapeutic mechanism of percutaneous tibial nerve stimulation?","volume":"2016","author":"Elder","year":"2016","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"10.1016\/j.purol.2020.09.004_bib0415","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12894-018-0322-y","article-title":"Characterizing the transcutaneous electrical recruitment of lower leg afferents in healthy adults: implications for non-invasive treatment of overactive bladder","volume":"18","author":"Sharan","year":"2018","journal-title":"BMC Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0420","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/nau.20651","article-title":"Percutaneous tibial nerve stimulation produces effects on brain activity: study on the modifications of the long latency somatosensory evoked potentials","volume":"28","author":"Finazzi-Agr\u00f2","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2020.09.004_bib0425","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/nau.23351","article-title":"The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: a systematic review","volume":"37","author":"Booth","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2020.09.004_bib0430","first-page":"188","article-title":"Effectiveness of short term percutaneous tibial nerve stimulation for non-neurogenic overactive bladder syndrome in adults: a meta-analysis","volume":"47","author":"Wibisono","year":"2015","journal-title":"Acta Med Indones"},{"key":"10.1016\/j.purol.2020.09.004_bib0435","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/nau.22251","article-title":"Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis","volume":"31","author":"Burton","year":"2012","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2020.09.004_bib0440","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.23843","article-title":"Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial","volume":"38","author":"Ram\u00edrez-Garc\u00eda","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2020.09.004_bib0445","first-page":"480","article-title":"Neuromodulative treatment of overactive bladder--noninvasive tibial nerve stimulation","volume":"103","author":"Svihra","year":"2002","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.purol.2020.09.004_bib0450","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00345-013-1112-5","article-title":"Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome","volume":"32","author":"Souto","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0455","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejogrb.2015.09.020","article-title":"Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial","volume":"196","author":"Manr\u00edquez","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.purol.2020.09.004_bib0460","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/00365590510031147","article-title":"A peripheric neuromodulation technique for curing detrusor overactivity: stoller afferent neurostimulation","volume":"39","author":"Karademir","year":"2005","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.purol.2020.09.004_bib0465","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejogrb.2015.05.014","article-title":"Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial","volume":"191","author":"Preyer","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.purol.2020.09.004_bib0470","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.juro.2009.05.045","article-title":"Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial","volume":"182","author":"Peters","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0475","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3109\/09513591003649815","article-title":"The outcome of adding peripheral neuromodulation (Stoller afferent neuro-stimulation) to anti-muscarinic therapy in women with severe overactive bladder","volume":"26","author":"Sancaktar","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.purol.2020.09.004_bib0480","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000350216","article-title":"Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: results of a randomized controlled crossover study","volume":"75","author":"Vecchioli-Scaldazza","year":"2013","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.purol.2020.09.004_bib0485","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2005.10.019","article-title":"Prognostic factors for successful percutaneous tibial nerve stimulation","volume":"49","author":"van Balken","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0490","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/nau.10111","article-title":"Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data","volume":"22","author":"Vandoninck","year":"2003","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2020.09.004_bib0495","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.juro.2012.11.175","article-title":"Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study","volume":"189","author":"Peters","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0500","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00345-018-2296-5","article-title":"Transcutaneous tibial nerve stimulation: 2\u00a0years follow-up outcomes in the management of anticholinergic refractory overactive bladder","volume":"36","author":"Leroux","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0505","article-title":"Factors associated with long-term use of percutaneous tibial nerve stimulation for management of overactive bladder syndrome","author":"Gordon","year":"2020","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.purol.2020.09.004_bib0510","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.juro.2017.01.078","article-title":"A new implanted posterior tibial nerve stimulator for the treatment of overactive bladder syndrome: 3-month results of a novel therapy at a single center","volume":"198","author":"van Breda","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0515","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.juro.2018.10.017","article-title":"Feasibility of a fully implanted, nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence","volume":"201","author":"MacDiarmid","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0520","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/j.2040-4603.2015.tb00596.x","article-title":"Neural control of the lower urinary tract","volume":"5","author":"de Groat","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1016\/j.purol.2020.09.004_bib0525","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.juro.2018.03.129","article-title":"Specific changes in brain activity during urgency in women with overactive bladder after successful sacral neuromodulation: a functional magnetic resonance imaging study","volume":"200","author":"Weissbart","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0530","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.eururo.2017.11.002","article-title":"Efficacy and safety of sacral and percutaneous tibial neuromodulation in non-neurogenic lower urinary tract dysfunction and chronic pelvic pain: a systematic review of the literature","volume":"73","author":"Tutolo","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0535","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.juro.2017.07.010","article-title":"Five-year followup results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation","volume":"199","author":"Siegel","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0540","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urology.2016.04.024","article-title":"Three-year follow-up results of a prospective, multicenter study in overactive bladder subjects treated with sacral neuromodulation","volume":"94","author":"Siegel","year":"2016","journal-title":"Urology"},{"issue":"Suppl 5","key":"10.1016\/j.purol.2020.09.004_bib0545","first-page":"S46","article-title":"How can we better manage drug-resistant OAB\/DO? ICI-RS 2018","volume":"38","author":"Chermansky","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2020.09.004_bib0550","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/nau.23515","article-title":"International Continence Society best practice statement for use of sacral neuromodulation","volume":"37","author":"Goldman","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2020.09.004_bib0555","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1464-410X.2011.10205.x","article-title":"Psychological and psychiatric factors as predictors for success in sacral neuromodulation treatment","volume":"108","author":"Marcelissen","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2020.09.004_bib0560","unstructured":"Wagner L, Alonso S, Le Normand L, Faix A, Kabani S, Castelli C, et al. Unilateral versus bilateral sacral neuromodulation test in the treatment of refractory idiopathic overactive bladder: A randomized controlled pilot trial. Neurourol Urodyn; [sous presse]."},{"key":"10.1016\/j.purol.2020.09.004_bib0565","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/nau.23349","article-title":"Sacral neuromodulation and pregnancy: results of a national survey carried out for the neuro-urology committee of the French Association of Urology (AFU)","volume":"37","author":"Roulette","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2020.09.004_bib0570","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0575","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.purol.2016.12.011","article-title":"Hyperactivit\u00e9 v\u00e9sicale idiopathique\u00a0: efficacit\u00e9 et tol\u00e9rance des traitements pharmacologiques\u00a0: revue de la litt\u00e9rature","volume":"27","author":"Moyson","year":"2017","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0580","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.purol.2013.09.020","article-title":"Les m\u00e9dicaments de la vessie","volume":"23","author":"Caremel","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0585","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.purol.2013.10.006","article-title":"Recommandations pour l\u2019utilisation de la toxine botulinique de type A (Botox\u00ae) dans l\u2019hyperactivit\u00e9 v\u00e9sicale r\u00e9fractaire idiopathique","volume":"23","author":"Hermieu","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0590","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2011.10.028","article-title":"Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study","volume":"61","author":"Denys","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0595","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"OnabotulinumtoxinA 100\u00a0U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0600","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0605","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.juro.2016.03.146","article-title":"Durable efficacy and safety of long-term onabotulinumtoxina treatment in patients with overactive bladder syndrome: final results of a 3.5-year study","volume":"196","author":"Nitti","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0610","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/jama.2016.14617","article-title":"Onabotulinumtoxin A vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial","volume":"316","author":"Amundsen","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.purol.2020.09.004_bib0615","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/JU.0000000000000656","article-title":"Cost-effectiveness of sacral neuromodulation versus OnabotulinumtoxinA for refractory urgency urinary incontinence: results of the ROSETTA randomized trial","volume":"203","author":"Harvie","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0620","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11934-019-0920-6","article-title":"What is new in neuromodulation?","volume":"20","author":"Moore","year":"2019","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.purol.2020.09.004_bib0625","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s11255-015-1100-3","article-title":"Patient preferences for treating refractory overactive bladder in the UK","volume":"47","author":"Hashim","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.purol.2020.09.004_bib0630","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1464-410x.1998.00474.x","article-title":"Detrusor myectomy for detrusor overactivity: a minimum 1-year follow-up","volume":"81","author":"Swami","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0635","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1464-410X.2005.05628.x","article-title":"Detrusor myectomy: long-term results with a minimum follow-up of 2\u00a0years","volume":"96","author":"Kumar","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2020.09.004_bib0640","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/bju.13246","article-title":"Conjoint Urological Society of Australia and New Zealand (USANZ) and Urogynaecological Society of Australasia (UGSA) Guidelines on the management of adult non-neurogenic overactive bladder","volume":"117","author":"Tse","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2020.09.004_bib0645","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1464-410x.1998.00549.x","article-title":"Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women","volume":"81","author":"Awad","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0650","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1464-4096.2001.001206","article-title":"Augmentation cystoplasty","volume":"88","author":"Greenwell","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2020.09.004_bib0655","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.eururo.2014.01.036","article-title":"Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: a single-center study","volume":"65","author":"Kuo","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0660","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/nau.24272","volume":"39","author":"Rovner","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2020.09.004_bib0665","doi-asserted-by":"crossref","first-page":"e1477","DOI":"10.6061\/clinics\/2020\/e1477","article-title":"Transcutaneous tibial nerve stimulation versus parasacral stimulation in the treatment of overactive bladder in elderly people: a triple-blinded randomized controlled trial","volume":"75","author":"Jacomo","year":"2020","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.purol.2020.09.004_bib0670","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/nau.20174","article-title":"Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial","volume":"24","author":"Peters","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2020.09.004_bib0675","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/nau.20544","article-title":"Dorsal genital nerve stimulation for the treatment of overactive bladder symptoms","volume":"27","author":"Goldman","year":"2008","journal-title":"Neurourol Urodyn"},{"issue":"Suppl 3","key":"10.1016\/j.purol.2020.09.004_bib0680","first-page":"S140","article-title":"Is there enough evidence to justify the use of laser and other thermal therapies in female lower urinary tract dysfunction? Report from the ICI-RS 2019","volume":"39","author":"Robinson","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2020.09.004_bib0685","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00192-020-04319-z","article-title":"Vaginal laser for overactive bladder syndrome","volume":"31","author":"Charalampous","year":"2020","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.purol.2020.09.004_bib0690","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0210-4806(09)74003-3","article-title":"Electroestimulaci\u00f3n del nervio tibial posterior para el tratamiento de la vejiga hiperactiva. estudio prospectivo y controlado","volume":"33","author":"Bellette","year":"2009","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.purol.2020.09.004_bib0695","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00192-010-1165-6","article-title":"Randomized trial of transcutaneous tibial nerve stimulation to treat urge urinary incontinence in older women","volume":"21","author":"Schreiner","year":"2010","journal-title":"Int Urogynecol J"},{"issue":"4","key":"10.1016\/j.purol.2020.09.004_bib0700","first-page":"B671","article-title":"Neuromodulation for overactive bladder with transcutaneous electrical nerve stimulation in adults\u00a0\u2013\u00a0a randomized clinical study","volume":"5","author":"Surbala","year":"2014","journal-title":"Int J Pharma Bio Sci"},{"key":"10.1016\/j.purol.2020.09.004_bib0705","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.juro.2010.06.113","article-title":"Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial","volume":"184","author":"Finazzi-Agr\u00f2","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0710","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.juro.2009.12.036","article-title":"Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial","volume":"183","author":"Peters","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0715","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000020134","article-title":"Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial","volume":"37","author":"Weil","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2020.09.004_bib0360","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0022-5347(05)67558-1","article-title":"Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety","volume":"163","author":"Hassouna","year":"2000","journal-title":"J Urol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S116670872030539X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S116670872030539X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:33:22Z","timestamp":1761114802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S116670872030539X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":72,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S116670872030539X"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2020.09.004","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement du syndrome clinique d\u2019hyperactivit\u00e9 v\u00e9sicale non neurologique r\u00e9fractaire","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2020.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}